Cambridge, MA · Founded 2022 · Privately Held (backing)
Operator of a biotechnology company intended to unlock cellular profiling and target discovery. Stipple Bio is based in Cambridge, MA and was founded in 2022. It was valued at $2.2 billion at its early-stage round in Apr 2026, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $65.1 million later-stage round in Mar 2026.
PMV mark · valuation
$2.2B
Oct 2026
Priced at
its early-stage round
Apr 2026
Total raised
$121.5M
Last round
Later Stage VC
Mar 2026
Cap table — not yet on record
Stipple Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stipple Bio with a free account
·Watch Stipple Bio: the Monday email on marks, rounds and moves